Search Results - "Silva, Leyre"
-
1
Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
Published in Frontiers in immunology (03-09-2018)“…Understanding mechanisms associated to dendritic cell (DC) functions has allowed developing new antitumor therapeutic vaccination strategies. However, these…”
Get full text
Journal Article -
2
Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
Published in Frontiers in immunology (24-01-2023)“…Current vaccines against SARS-CoV-2, based on the original Wuhan sequence, induce antibodies with different degrees of cross-recognition of new viral variants…”
Get full text
Journal Article -
3
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
Published in Frontiers in immunology (02-11-2022)“…Immune checkpoint inhibitor (ICI)-based immunotherapy in triple negative breast cancer (TNBC) is achieving limited therapeutic results, requiring the…”
Get full text
Journal Article -
4
Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance
Published in Liver transplantation (01-09-2013)“…Recipients of liver transplantation (LT) may develop immunological tolerance. Factors predictive of tolerance are not clearly understood. Transplant recipients…”
Get full text
Journal Article -
5
Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
Published in Frontiers in immunology (03-03-2023)“…[This corrects the article DOI: 10.3389/fimmu.2022.1044025.]…”
Get full text
Journal Article -
6
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
Published in Frontiers in immunology (10-10-2022)“…Vaccination using optimized strategies may increase response rates to immune checkpoint inhibitors (ICI) in some tumors. To enhance vaccine potency and improve…”
Get full text
Journal Article -
7
Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma
Published in Cancers (16-11-2020)“…Therapies based on immune checkpoint inhibitors (ICPI) have yielded promising albeit limited results in patients with hepatocellular carcinoma (HCC). Vaccines…”
Get full text
Journal Article -
8
Neoantigens as potential vaccines in hepatocellular carcinoma
Published in Journal for immunotherapy of cancer (01-02-2022)“…BackgroundNeoantigens, new immunogenic sequences arising from tumor mutations, have been associated with response to immunotherapy and are considered potential…”
Get full text
Journal Article -
9
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer
Published in Oncoimmunology (03-04-2018)“…Tumor infiltrating lymphocytes have been associated with a better prognostic and with higher response rates in patients treated with checkpoint inhibiting…”
Get full text
Journal Article -
10
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Published in Molecular therapy. Methods & clinical development (01-01-2015)“…The lack of antiviral cellular immune responses in patients with chronic hepatitis C virus (HCV) infection suggests that T-cell vaccines may provide…”
Get full text
Journal Article -
11
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
Published in Cancer Immunology, Immunotherapy (01-03-2019)“…Immune checkpoint inhibitors are currently tested in different combinations in patients with advanced hepatocellular carcinoma (HCC). Nivolumab, an anti-PD-1…”
Get full text
Journal Article -
12
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
Published in Cancer letters (28-02-2021)“…Analyzing immunomodulatory elements operating during antitumor vaccination in prostate cancer patients and murine models we identified IL-10-producing DC as a…”
Get full text
Journal Article -
13
IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination
Published in Oncotarget (10-01-2017)“…Vaccination induces immunostimulatory signals that are often accompanied by regulatory mechanisms such as IL-10, which control T-cell activation and inhibit…”
Get full text
Journal Article -
14
FRI476 - Identification of neoantigens as potential vaccines in hepatocellular carcinoma
Published in Journal of hepatology (01-08-2020)Get full text
Journal Article -
15
Identification of neoantigens as potential vaccines in hepatocellular carcinoma
Published in Journal of hepatology (01-08-2020)Get full text
Journal Article -
16
Immune monitoring of immunosuppression withdrawal of liver transplant recipients
Published in Transplant immunology (01-10-2015)“…Abstract Several studies have shown that some liver transplant recipients may tolerate immunosuppression withdrawal. Mechanisms and biomarkers of tolerance are…”
Get full text
Journal Article -
17
Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells
Published in Hepatology (Baltimore, Md.) (01-07-2011)“…Injection of dendritic cells (DCs) presenting viral proteins constitutes a promising approach to stimulate T cell immunity against hepatitis C virus (HCV)…”
Get full text
Journal Article -
18
Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance: Tolerance in Lt
Published in Liver transplantation (01-09-2013)Get full text
Journal Article -
19
Vaccination Against Hepatitis C Virus With Dendritic Cells Transduced With an Adenovirus Encoding NS3 Protein
Published in Molecular therapy (01-01-2008)“…Chronic infection by hepatitis C virus (HCV) is characterized by the absence of efficient antiviral T-cell responses. Thus, vaccination strategies to induce…”
Get full text
Journal Article